ep

Showing 2 posts of 2 posts found.

Sales forecasts leave Sovaldi top and Januvia lagging

May 23, 2014
Sales and Marketing Gilead, Januvia, Merck, diabetes, ep, hep C, sovaldi

Sovaldi has topped analysts’ estimates for future growth but Merck’s big-selling diabetes drug Januvia is falling by the wayside. This …

GSK image

GSK tops drug approval rates

March 7, 2014
Medical Communications, Sales and Marketing FDA, GSK, J&J, JJ, Merck, Sanofi, ep, evaluate pharma, lilly, nme

GlaxoSmithKline is riding high when it comes to the approval of new medicines but US firm Lilly is falling behind. …

The Gateway to Local Adoption Series

Latest content